Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030

ALTADENA, Calif. - Aug. 13, 2020 - PRLog -- The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A study of the various grants that have been awarded to research institutes engaged in projects related to continuous manufacturing, between 2014 and 2019

§  An in-depth analysis of the various patents that have been filed / granted related to continuous manufacturing till 2019

§  Initiatives taken by the leading pharmaceutical companies (in terms of revenues), covering both partnered as well as in-house projects.

§  A review of the companies offering modular facilities / modular cleanrooms

§  A case study of the companies offering technologies / equipment

§  A case study on the roadmap for the adoption of continuous manufacturing technique

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Purpose of Manufacturing

§  In-House

§  Contract service

§  Scale of Operation

§  Commercial

§  Preclinical / Clinical

§  Type of Continuous Manufacturing related Service

§  API Manufacturing

§  End Product manufacturing

§  Type of Drug Molecule

§  Biologic

§  Small Molecule

§  Type of dosage form

§  Solid

§  Liquid

§  Key Geographical Regions

§  North America

§  Europe

§  Asia Pacific

§  Transcripts of interviews held with the following senior level representatives of stakeholder companies

§  Andrea Adamo, Founder and Chief Executive Officer, Zaiput Flow technologies

§  Bayan Takizawa, Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals

§  Nick Thomson, Senior Director Chemical Research and Development, Pfizer

§  Himanshu Gadgil, Director and Chief Scientific Officer, Enzene Biosciences

§  Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)

§  Ian Houson, Technical Project Manager, Continuous Manufacturing and Crystallization, University of Strathclyde

Key companies covered in the report (https://www.rootsanalysis.com/reports/view_document/conti...)

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com